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Abstract
Background: The adaptation of pathogenic fungi to the host environment via large-scale genomic changes is a
poorly characterized phenomenon. Cryptococcus neoformans is the leading cause of fungal meningoencephalitis in
HIV/AIDS patients, and we recently discovered clinical strains of the fungus that are disomic for chromosome 13.
Here, we examined the genome plasticity and phenotypes of monosomic and disomic strains, and compared their
virulence in a mouse model of cryptococcosis
Results: In an initial set of strains, melanin production was correlated with monosomy at chromosome 13, and
disomic variants were less melanized and attenuated for virulence in mice. After growth in culture or passage
through mice, subsequent strains were identified that varied in melanin formation and exhibited copy number
changes for other chromosomes. The correlation between melanin and disomy at chromosome 13 was observed
for some but not all strains. A survey of environmental and clinical isolates maintained in culture revealed few
occurrences of disomic chromosomes. However, an examination of isolates that were freshly collected from the
cerebrospinal fluid of AIDS patients and minimally cultured provided evidence for infections with multiple strains
and copy number variation.
Conclusions: Overall, these results suggest that the genome of C. neoformans exhibits a greater degree of
plasticity than previously appreciated. Furthermore, the expression of an essential virulence factor and the severity
of disease are associated with genome variation. The occurrence of chromosomal variation in isolates from AIDS
patients, combined with the observed influence of disomy on virulence, indicates that genome plasticity may have
clinical relevance.
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Background
The adaptation of pathogens to the host environment is
a critical determinant of the outcome of disease. Well-
documented examples include antigenic variation in
parasites and fungi to evade adaptive immune responses,
viral evasion of immune detection, and phase variation
in bacterial pathogens [1-5]. For fungi that attack
humans, accumulating evidence indicates that genomic
plasticity also contributes to adaptation to the host. For
example, surveys of clinical isolates of Candida albicans
reveal extensive variation in karyotypes and chromo-
some copy number, and genomic changes have been
shown to arise during infection [6-11]. Furthermore,
aneuploidy is common in laboratory strains of C. albi-
cans, and this trait, along with isochromosome forma-
tion, is associated with resistance to azole antifungal
drugs [10-15]. Genome-wide variation also occurs dur-
ing infections caused by Cryptococcus neoformans,t h e
leading cause of fungal meningoencephalitis in patients
with HIV/AIDS [16]. For example, Fries et al. [17] docu-
mented karyotypic changes and gross chromosomal
rearrangements or deletions in sequential isolates from
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in mice also confirmed that karyotypic changes occur
during passage in the host [17].
Previously, we employed comparative genome hybridi-
zation (CGH) to characterize chromosomal variations
among strains of C. neoformans that differed in capsular
serotypes, molecular subtypes and/or ploidy, including
hybrids of different serotype [18]. C. neoformans gener-
ally exists as a haploid yeast in the environment and
patients, although natural hybrid strains are also found
and they appear to be diploid or aneuploid [19-21]. Our
CGH analysis of three strains of hybrid serotype (AD
strains) revealed that these strains were aneuploid with
preferential retention of chromosome 1 from the sero-
type A genome [18]. This study also evaluated four clin-
ical isolates of serotype A and identified two that were
disomic for chromosome 13 [18]. Strains of serotype A
are responsible for the majority of clinical cases of cryp-
tococcosis [22-24]. The two disomic clinical isolates
came from AIDS patients in Argentina (CBS7779) and
Australia (WM626). We examined these strains for the
three most important virulence factors, formation of the
polysaccharide capsule, deposition of melanin in the cell
wall, and growth at 37°C. The strains were phenotypi-
cally similar to the standard reference strain in capsule
production and growth at 37°C but they exhibited
reduced formation of melanin [18]. This result suggested
that phenotypic differences related to virulence might be
correlated with variation in chromosome copy number.
More recently, polyploidy has been described as a fea-
ture of C. neoformans cells in the host [25,26].
Variation in chromosome content may be more com-
mon in C. neoformans than previously recognized. In
addition to the occurrence of disomy in clinical strains
[ 1 8 ] ,S i o n o ve ta l .[ 2 7 ]r e c e n t l yf o u n dt h a ts e l e c t i o nf o r
growth in the presence of elevated levels of the antifun-
gal drug fluconazole resulted in disomy. Specifically,
strains of C. neoformans exhibited heteroresistance in
which a minor subpopulation of cells was present that
could tolerate levels of the drug above the normal mini-
mal inhibitory concentration. The resistant subpopula-
tion represented 0.3-0.6% of the starting cells and CGH
analysis revealed that the heteroresistant isolates were
disomic for chromosome 1, as well as other chromo-
somes (i.e., 4, 10, 14) depending on the level of resis-
tance. Notably, chromosome 1 carries both ERG11,
encoding lanosterol-14-a-demethylase, the target of flu-
conazole, and AFR1, encoding an ABC transporter asso-
ciated with susceptibility to azoles. Subsequent genetic
analysis confirmed a role for these genes in the associa-
tion of disomy with resistance to fluconazole. Sionov et
al. [27] proposed that fluconazole exposure may induce
chromosome amplification rather than simply select for
disomic strains arising by spontaneous chromosomal
mis-segregation. The clinical relevance of chromosomal
aberrations is further supported by other recent observa-
tions. As mentioned above, changes in genome copy
number resulting in polyploidy are observed for so-
called giant cells of C. neoformans arising during pul-
monary infection [25,26]. In addition, Desnos-Ollivier et
al. [28] discovered that ~18% of patients have mixed
infections with strains of different mating type, serotype,
genotype and ploidy.
In the current study, we extended our analysis of dis-
omy in C. neoformans by testing the hypothesis that the
copy number of chromosomes affects the expression of
the virulence trait melanin and the severity of disease in
experimentally infected mice. The results confirmed that
disomy at chromosome 13 is correlated with both loss
of melanin formation and reduced murine virulence.
However, we also discovered copy number changes for
other chromosomes in strains with altered melanin for-
mation, and the correlation with chromosome 13 was
not always observed. The additional changes in chromo-
some copy number were detected by screening strains
that were passaged in culture or through mice. The dis-
covery of disomy in a clinical isolate and its influence
on virulence, suggested that disomy might arise during
human infections. We therefore screened a collection of
clinical and environmental strains, as well as isolates
obtained directly from the cerebrospinal fluid of HIV/
AIDS patients, and we found additional examples of var-
iation in chromosome copy number. Overall, this study
suggests that variation in the expression of virulence
traits among strains and their ability to adapt to the
mammalian host environment are influenced by changes
in chromosome copy number.
Results
Disomy at chromosome 13 of C. neoformans is correlated
with reduced melanin formation
In comparison to the serotypeAs t r a i nH 9 9 ,t h er e f e r -
ence strain that is commonly used to investigate the
virulence of C. neoformans, two clinical isolates,
CBS7779 and WM626, were reported to have signifi-
cantly diminished production of the major virulence fac-
tor melanin [18]. Since both strains were shown by
comparative genome hybridization (CGH) to be disomic
for chromosome 13 (chr 13), we hypothesized that their
reduction in melanin formation was due to chromoso-
mal variation such as disomy. We focused our subse-
quent work on CBS7779 because this strain was similar
in virulence to strain H99, and strain WM626 was atte-
nuated for virulence (see below). To examine the rela-
tionship between melanin formation and disomy, we
initially screened strain CBS7779 for variants that
showed a more pronounced defect in melanin produc-
tion (hereafter called white variants). These were readily
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highly melanized colonies. This screen yielded 12 black
isolates (designated B1-B12), and 12 white isolates (W1-
W12) for further analysis. These isolates generally main-
tained their melanin phenotypes upon repeated streak-
ing on L-DOPA medium. Each of the 12 black and 12
white melanin variants were first examined by quantita-
tive PCR using primers for genes at three positions
along chr 13 (CNN00820, CNN01890 and CNN02400)
to determine the copy number of the chromosome.
Based on the genome sequences of serotype A and D
strains [29,30], the actin gene on chr 1 (CNA04650) and
a gene on chr 4 (CND00707) were employed as a single
copy controls. In addition, the SMG1 gene on chr 4 was
used as a control because Fraser et al. [31] showed that
this gene was duplicated in the serotype D strain JEC21,
but not in strain H99. The PCR analysis revealed that
each of the 12 black variants was monosomic at chr 13
and chr 4. All 12 of the white variants were monsomic
at chr 4 but nine were disomic and three were trisomic
at chr 13 (Table 1). These analyses were repeated
several times on independent DNA samples with identi-
cal results. The PCR results were also confirmed and
extended by CGH analysis on independent DNA sam-
ples that revealed monosomy for chr 13 in the three
black variants (B4-6) and disomy in the three white var-
iants (W1-W3) (Figure 1).
In addition to a correlation between reduced mela-
nization and disomy at chr 13, we also found that
white strains were more susceptible to the antifungal
drug fluconazole, and to the trafficking inhibitors bre-
feldin A (BFA) and monensin (Figure 2A and data
not shown). The latter inhibitors are relevant to viru-
lence because we previously showed that they inhibit
the secretory pathway needed for capsule formation
[32]. In addition, several secreted enzymes contribute
to virulence in C. neoformans including phospholipase
B, urease and laccase [33]. The black and white var-
iants exhibited no differences in capsule formation or
their responses to oxidative and nitrosative stress
(data not shown). However, the white strains did dis-
play slower growth in liquid culture (Figure 2B).
Overall, these results established a correlation
between disomy at chr 13 and phenotypic traits with
potential relevance to virulence and clinical outcome,
i.e., melanin formation, secretion and susceptibility to
fluconazole.
Disomic, non-melanized strains have reduced virulence
The white and black variants with defined chromosomal
complements provided the opportunity to determine the
effect, if any, of variation in chromosome copy number
on virulence in a mouse inhalation model of cryptococ-
cosis. Cells from the same cultures that were employed
to isolate DNA for the CGH analysis of the three white
(W1-3) and black (B4-6) variants were also used as
inoculum in the virulence assays. Initially, we performed
a pilot virulence test by inoculating three mice with
each of the three black isolates and the three white iso-
lates. This study also included strain H99 because of its
well-characterized and high level of murine virulence, as
well as the original CBS7779 and WM626 strains. The
results indicated that CBS7779 was similar in virulence
to strain H99, WM626 was attenuated for virulence, and
the white (disomic) variants were less virulent than the
black (monosomic) variants (Figure 3A). These results
were substantiated in a larger study that employed 10
mice for each variant. As shown in Figure 3A, the white
variants again showed reduced virulence (i.e., prolonged
survival) compared with the black variants.
Infections with the black and white variants produced
similar fungal burdens in the lungs and the brains of
infected mice, although greater variation between mice
was observed for the black variants in the brain (Figure
3B). Considering that white variants grew more slowly
Table 1 Analysis of gene copy number in CBS7779
variants relative to strain H99.
Strain SMG1 (chr 4) CNN00820 (chr 13) CND00707 (chr 4)
H99 1 1 1
JEC21 2.33 1.07 1.22
CBS7779 B1 1.1 1.09 ND
CBS7779 B2 1.08 0.95 ND
CBS7779 B3 1.16 1.08 ND
CBS7779 B4 1.1 1.03 1.08
CBS7779 B5 1.24 0.99 1.28
CBS7779 B6 1.16 1.01 1.37
CBS7779 B7 1.27 0.68 ND
CBS7779 B8 1.38 1.34 ND
CBS7779 B9 1.43 1.01 ND
CBS7779 B10 1.38 0.74 ND
CBS7779 B11 1.26 1.15 ND
CBS7779 B12 1.36 0.99 ND
CBS7779 W1 1.3 1.84 ND
CBS7779 W2 1.16 2.01 ND
CBS7779 W3 1.1 1.97 ND
CBS7779 W4 1.23 2.23 1.36
CBS7779 W5 1.11 1.85 1.24
CBS7779 W6 0.96 1.78 1.19
CBS7779 W7 1.29 1.8 ND
CBS7779 W8 1.13 2.66 ND
CBS7779 W9 1.25 2.89 ND
CBS7779 W10 1.15 2.01 ND
CBS7779 W11 1.15 2.87 ND
CBS7779 W12 1.13 3.1 ND
Quantitative PCR was used to examine copy number (2
-ΔΔCt method).
ND, not determined
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Page 3 of 19in culture and the black variants were more lethal, their
comparable fungal loads in mice were unexpected.
These results suggested that other properties besides
fungal proliferation were contributing to disease, and we
therefore examined lung and brain tissue by histopathol-
ogy to more closely compare the infections. As shown in
Figure 4, lungs infected with the black strain (CBS7779-
B4) exhibited more extensive airway remodeling com-
pared with the lungs infected with the white strain
(CBS7779-W2), which showed greater damage to the
lung parenchymal as indicated by thickened tissue and
reduce air space. These differences in pulmonary histo-
pathology were more pronounced at days 14 and 21
than at day 7 (Figure 4 and data not shown). The infec-
tions with both strains resulted in similar levels of peri-
vascular and peribronchial inflammation (Figure 4).
Overall, the distinct virulence properties of the black
and white strains are associated with differences in the
type of damage observed in infected lung tissue.
Disomy at chromosome 13 influences gene expression
A microarray comparison of the transcriptomes of the
black and white isolates was performed to determine
whether disomy at chr 13 influences gene expression
(Figure 5). For this study, CBS7779 isolates W2 and B4
w e r eg r o w ni nl i q u i dL - D O P Am e d i u mf o rs i xh o u r s
Figure 1 Comparative genome hybridization reveals disomy for chr 13 in melanin variants. A custom CGH array (Roche-NimbleGen) for
the reference genome of strain H99 was used to examine the black (CBS7779-B4, CBS7779-B5 and CBS7779-B6) and white (CBS7779-W1,
CBS7779-W2 and CBS7779-W3). The x-axis represents the position of probes arranged in the order of their chromosomal location. The y-axis
denotes the relative hybridization signal intensity that was plotted as the log2 value. Each spot represented a running average value of
hybridizations for a genomic segment of 1,300 bps across the chromosomes. All three white strains showed disomy on chromosome 13.
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Page 4 of 19Figure 2 Melanin variants show differences in growth as well as sensitivity to fluconazole and brefeldin A. (A) Dilutions of the melanin
variants were spotted on the media indicated above the panels with YNB medium as the control for growth in the presence of fluconazole (5
μg/ml) and brefeldin A (20 μg/ml). Growth on the L-DOPA plate demonstrates the difference in melanin production by the strains. The plates
were incubated for 2 days at 30°C before being photographed. (B) Growth of the CBS7779 strain and three black and three white melanin
variants was measured in a TECAN plate reader. The assay was repeated three times with similar results.
Figure 3 Monsomic and disomic melanin variants differ in their virulence in a mouse inhalation model but show similar fungal loads
in brain and lung tissue. (A) Three female BALB/c mice were inoculated intranasally with each of the strains indicated, and the survival of the
mice was monitored (left graph). The strain H99 was the most virulent, WM626 did not cause illness during the experiment, and the white
(disomy) variants showed reduced virulence compared with CBS7779 and the black variants. Ten female BALB/c mice were also challenged by
intranasal inoculation with cells of either the CBS7779 strain or the black or white variants. The survival of the mice was monitored (center
graph). The white (disomy) strains showed a difference in virulence from the black strains and from the parental CBS7779 strain. The data on the
virulence of the white and black strains was combined, and the white strains showed less virulence than the black strains by the log rank test (P
< 0.001) (right graph). (B) Examination of the fungal load in lung (a) and brain (b) tissue from the mice infected in (A) with the white or black
melanin variants, or with the original CBS7779 strain. The organs from each of the ten mice per inoculated strain were harvested and analyzed
for fungal burden. Serial dilutions of the homogenates were plated on Sabouraud dextrose agar plates, and colony-forming units were counted
after incubation for 48 h at 30°C. Each dot indicates the result for a single mouse.
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Page 5 of 19and RNA was prepared for hybridization. The analysis
revealed that 127 genes were down regulated and 168
were up regulated by two-fold or more in the disomic
W2 strain relative to the B4 strain (Additional files 1
and 2). Only two of the down-regulated genes in W2
were on chr 13, compared with 97 of the up-regulated
genes. Chr 13 is 756,744 bp in length and contains
~234 annotated genes (see Materials and Methods).
Thus, the array data indicated that 41% of the chr 13
genes were up regulated two-fold or more in associa-
tion with disomy for this chromosome. We also exam-
ined the expression of genes on chr 13 (or other
chromosomes) that might influence melanin formation
a n di d e n t i f i e dt h eCCC2 gene (CNAG_06415) as a
potential candidate. Walton et al. [34] found that loss
of CCC2 results in a melanin defect, and this gene
encodes a transporter that may load copper onto the
laccase enzyme that catalyzes the polymerization of
melanin. However, the expression of CCC2 was not
substantially different between the B4 and W2 strains
(~1.5X higher in the B4 strain) and additional work
will be needed to test whether this subtle difference
influences melanization.
Copy number variation at other chromosomes also
correlates with melanin formation
To further examine the association between chromosome
copy number and melanization, we plated the white
strains CBS7779-W2 and CBS7779-W3 on L-DOPA
medium and screened for “second generation” black var-
iants under the same conditions employed earlier for the
parental strain CBS7779. These variants were readily
detected and we used CGH to examine the complement
of chromosomes in randomly selected colonies (Figure
6A, Table 2). All four of the black variants tested main-
tained the initial disomy at chr 13 that was present in the
starting strains, but they were also disomic for chr 4 (var-
iant W3-BB), chr 12 (W2-BB and W3-BC) or both chr4
and 12 (W2-BA). A subsequent comparison of the tran-
scriptomes of strains W2-BA and B4 also revealed ele-
vated transcription of many of the genes on chr 4, 12 and
13 (Additional file 3). The results for chr 4 and chr 13 in
these strains were confirmed by qPCR (data not shown).
With regard to melanin formation in the strains, we
hypothesize that disomy at chr 4 and/or chr 12 may have
compensated for disomy at chr 13. The examination of a
random white colony from the starting strain W2
Figure 4
Figure 4 Histopathology of lung tissue infected with melanin variants. Thin sections of pulmonary tissue from the uninfected mice (A, D,
PBS control), or mice infected with either CBS7779-W2 (B, E) or CBS7779-B4 (C, F) (21 days post-inoculation, dpi) were stained with hematoxylin
and eosin (H&E). The inflammatory response at 21 days post infection (dpi) was similar to that on 14 dpi (data not shown). Compared to the
control (A), the gas exchange area in CBS7779-W2 infected lungs was largely reduced due to tissue thickening (B). Lung tissues were severely
damaged in CBS7779-B4 infected mice (C). No marked inflammatory response was observed in control (D), while the infection by either
CBS7779-W2 (E) or CBS7779-B4 (F) caused similar levels of peribronchial inflammation. Blood vessels within the lungs infected with CBS7779-W2
(E) were surrounded by more inflammatory infiltrates than those within CBS7779-B4 infected lungs (F). Scale bar: 100 μmi nA ,B ,C ;1 0μmi nD ,
E, F).
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additional changes occurred for segments of chr 3, 5, 12
and 14 (Table 2, Additional file 4).
Three second-generation white variants (B1-WA, B1-
WB, B1-WC) from the monosomic black strain CBS7779-
B1 were also examined and found to show changes in
additional chromosomes (Figure 6A, Table 2). By CGH, (i)
strain B1-WA had an increase in the number of copies of
segments of chr 3 and chr 11, (ii) B1-WB was disomic for
chr13 and showed duplications of segments of chr 3, chr 5
and chr 11, and (iii) strain B1-WC had duplications of chr
13, chr 6 and a segment of chr 5. These results and those
described below indicated that changes in copy number
occurred for several chromosomes and involved partial or
complete chromosome duplication. In some cases,
changes in melanization correlated with changes in speci-
fic chromosomes (i.e., chr 4, 12, and 13). However, the
observed variation for part or all of four additional chro-
mosomes (chr 3, 5, 11, 14) suggests that genome plasticity
and/or other factors, such as background mutations, may
also influence melanization. Overall, these results indicate
that changes in chromosome copy number readily occur
in the CBS7779 variants.
Chromosome copy number variation is detected after
passage in mice
We next tested whether passage through mice influ-
enced the transitions from the monosomic and disomic
states. Initially, we examined the transition from disomy
to monosomy by examining colonies recovered from the
mice employed in the virulence assay with the three
white strains CBS7779-W1, -W2 and -W3 (Figure 3A).
To screen for melanin formation as an indicator of dis-
omy, we determined the proportion of black variants in
the starting inoculum of each strain by plating ~30,000
cells of each strain on L-DOPA medium. The W1
inoculum yielded nine black colonies (0.03%) and both
W2 and W3 produced six (0.02%). We then determined
the fungal burden in the lungs and brains of each
mouse (Figure 3B) and screened ~50,000 colonies from
each inoculated group (W1-W3) for black colonies. We
found the following average percentages of black
Figure 5
Figure 5 Gene expression on chromosome 13 differs for the monosomic and disomic melanin variants. A heat map is shown for the
profiles of gene expression of CBS7779-B4 compared to CBS7779-W2 as detected by microarray anlaysis. A total of six arrays including three
biological repeats and dye-swap sets were performed. Each column (lane 1 to 6) represents a microarray experiment and each row represents
the expression of a gene on the array arranged by its chromosomal position. The relative expression levels are depicted as shown by the color
bar. A summary of the numbers of differentially regulated genes for each chromosome in the disomic strain CBS7779-W2, compared to those in
CBS7779-B4, is given on the right.
Hu et al. BMC Genomics 2011, 12:526
http://www.biomedcentral.com/1471-2164/12/526
Page 7 of 19Figure 6
Figure 6 Copy number variation occurs at the other chromosomes in strains derived from CBS7779. Genome hybridization to compare
“second generation” black strains (A) and white strains (B) to the genome of the reference strain H99. The CGH data for the parental strains
CBS7779-W2, -W3 and -B1 are shown in Figure 1 and Additional file 4. The chromosome color labels for the hybridizations with the strains W2-
BA, W3-BB and B1-WB come from a separate experiment and are therefore different from the labels used for the other strains.
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Page 8 of 19variants in brain (B) and lung (L) tissue: W1 (B: 0.08%,
L: 0.32%), W2 (B: 0.06%, L: 0.22%), W3 (B: 0.05%, L:
0.30%). It appeared from these data that the percentage
of black colonies recovered from the brain was lower
than that recovered from the lung. This result may indi-
cate a tissue-specific influence on the appearance of
melanin variants.
From mice inoculated with thet h r e ew h i t es t r a i n s ,w e
randomly selected 10 white and 14 black colonies and ana-
lyzed their chromosome copy numbers. Analysis by qPCR
revealed that nine of the white isolates and seven of the
black isolates from mice were disomic for chr 13 (data not
shown). As with the in vitro analysis, this finding indicates
that some strains can recover the ability to form melanin
while still maintaining disomy at chr13. Subsequent CGH
analysis of seven black colonies revealed that two had
become monosomic at all chromosomes, three had
retained the disomy at chr 13 and gained disomy for chr 4,
one had lost disomy at chr 13 but gained disomy at chr 4
with a segmental change in chr 14, and one retained dis-
omy at chr 13 with a elevated copy number of both chr 4
and 12 (Figure 6B, Table 2 and Additional file 5). These
results are similar to those obtained with the second-gen-
eration black colonies from cultures (described above),
where disomy at chr 4 and/or chr 12 correlated with the
restoration of melanin formation in strains originally diso-
mic for chr 13. Three white colonies recovered from mice
infected with white strains maintained disomy at chr 13
(Figure 6B, Table 2, Additional file 5).
We also examined whether disomy at chr 13 arises in
t h eh o s tb yi n o c u l a t i n ge a c ho fs i xm i c ew i t h~1 0 0 0
cells of the black strain B4. The starting inoculum did
not contain white variants among ~30,000 colonies
screened prior to inoculation of mice. Mice were sacri-
ficed 24 days after infection and a screen of 2933 colo-
nies from homogenized brain tissue did not reveal any
Table 2 Summary of chromosome changes in second-generation black and white variants collected in culture and
from infected mice.
Starting strain/color Aberrant chromosome 2
nd Generation strain
a/pigment Aberrant chromosome(s)
Strains collected in culture
White to black
W2/white Chr 13 W2-BA/black Chr 13, 4, 12
W2/white Chr 13 W2-BB/black Chr 13, 12
b
W3/white Chr 13 W3-BB/black Chr 13, 4
W3/white Chr 13 W3-BC/black Chr 13, 12
White to white
W2/white Chr 13 W2-WB/white Chr 13 (3, 5, 12, 14)
b
Black to white
B1/black none B1-WA/white Chr 3
b,1 1
b
B1/black none B1-WB/white Chr 13 (3, 5, 11)
b
B1/black none B1-WC/white Chr 13, 5
b,6
Strains collected from mice
White to black
W2/white Chr 13 W2-MB3/black Chr 13, 4
W2/white Chr 13 W2-MB4/black Chr 13, 4
W2/white Chr 13 W2-MB5/black none
W2/white Chr 13 W2-MB7/black Chr 13, 4, 12
W2/white Chr 13 W2-MB8/black Chr 13, 4
W3/white Chr 13 W3-MB13/black Chr 4, 14
b
W3/white Chr 13 W3-MB16/black none
White to white
W2/white Chr 13 W2-MW1/white Chr 13
W2/white Chr 13 W2-MW2/white Chr 13
W3/white Chr 13 W3-MW6/white Chr 13
Black to white
B6/black none B6-MW10/white none
B6/black none B6-MB20/white none
aThe second generation strains are named after the starting strain followed by the color (B = black and W = white) and a letter or number designation. In the
case of strains collected from mice, an M is added before the letter indicating color.
bThese chromosomes show segmental changes. Note that some chromosomes show an elevated copy number but not full disomy perhaps indicating variability
among cells in the population.
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Page 9 of 19white colonies. However, a screen of ~50,000 colonies
from lung tissue yielded 27 white colonies, and subse-
q u e n tq P C Ra n a l y s i so f1 3o ft h e s ew h i t ei s o l a t e s
revealed that five were disomic for chr 13 (data not
shown). In contrast, six randomly selected black colonies
that arose from lung tissue were found to be monoso-
mic for chr 13. Although we have not examined other
chromosomes, this analysis confirmed that the transition
from monosomy to disomy at chr 13 occurs during
infection, as well as in vitro. However, it was also clear
that other mechanisms besides disomy at chr 13, such
as the accumulation of background mutations, may
result in reduced melanin production.
Disomy at chromosome 13 occurs in a laboratory strain
but does not correlate with melanin formation
The link between disomy at chr 13 and melanin forma-
tion was discovered in strain CBS7779 during a survey
of genome variation in serotype A strains, and it is pos-
sible that strain CBS7779 is particularly prone to
changes in chromosome copy number. To determine
whether these results are strain-specific or a general
property of C. neoformans, we investigated whether dis-
omy readily occurs at chr 13 in a laboratory strain. We
were also interested in testing whether specific chromo-
somes could be amplified through selection. We there-
fore tagged chr 13 in laboratory strain H99 by insertion
of a neomycin resistance marker and then plated tagged
strains on medium containing neomycin at 10X the con-
centration generally employed for selection of DNA
transformants (2 mg/ml). Four tagged transformants (#s
32, 33, 34 and 35) were plated on L-DOPA medium
containing neomycin at 10X the inhibitory concentra-
tion (10 × 10
6 cells per plate). After five days of incuba-
tion, approximately 10 colonies were observed on each
plate. White and black colonies were identified on L-
DOPA medium with neomycin and the isolates were
characterized for capsule formation and cell morphology
(Additional file 6). Two of the white variants showed a
larger cell size and two showed larger capsules, which
indicated phenotypic changes beyond melanin forma-
tion. Subsequent CGH analysis of four white and two
black isolates revealed that only two strains, one white
(35W1) and one black (32B7), had become disomic at
chr 13, and both of these strains also had changes at chr
14. One white strain (32W1) had changes at chr 11 and
chr 14, and three strains (two white and one black) had
no chromosome changes. The CGH results for the three
strains with chromosomal changes are shown in Figure
7. Overall, these results indicate that elevated copy num-
ber at chr 13 could be achieved in a laboratory strain
through tagging a specific chromosome with a selectable
marker. However, this approach was only partially effec-
tive, and in one strain, an elevated chr 13 copy number
did not correlate with reduced melanin formation.
Disomy is relatively rare in a collection of clinical and
environmental strains
Our initial examination of four serotype A strains
revealed two (CBS7779 and WM626) that were disomic
Figure 7 Targeted selection for disomy at chromosome 13 yields strains with changes in several chromosomes.T h eC G Hd a t aa r e
shown for three of the six strains selected for neomycin resistance in a derivative of the H99 strain tagged on chr 13 with the neomycin
resistance gene. Elevated copy numbers are evident for chr 13 in the white strain 35W1 but also for the black strain 32B7. Copy number
changes are also evident for chr 9, 11 and 14 in some of the strains.
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disomy, we used CGH to survey 19 additional clinical
and environmental serotype A strains of different global
origins (Additional files 7 and 8). Only two of the iso-
lates showed chromosome copy number changes (Figure
8). Specifically, strain A5-35-17 appeared to have an ele-
vated copy number for chr 1, and strain JP1086 con-
tained an amplified region on chr 7. Both have the A5/
M5 genotype as defined by multilocus sequence typing
(MLST) and amplified fragment length polymorphism
(AFLP) analyses [23,24]. The CGH analysis did reveal
that strains A7-35-23 and C45 had a greater overall
level of sequence divergence from H99; this result is
consistent with the fact that these strains have a VNII
molecular type compared with the VNI subtype of strain
H 9 9[ 2 4 ] .W ep r e v i o u s l yd e m o n s t r a t e dt h ea b i l i t yo f
CGH to distinguish the three molecular types of sero-
type A strains, VNI, VNII and VNB [18]. These isolates
have been stored and subcultured since the time of their
isolation from patients or the environment, and this
prolonged period of in vitro growth in complete med-
ium may have selected for strains with a haploid com-
plement of chromosomes.
Chromosome copy number variation is present in isolates
from AIDS patients
We next examined whether chromosome copy number
variation could be detected in isolates freshly collected
from the cerebrospinal fluid of AIDS patients. Multiple
colonies were obtained upon plating cerebral spinal fluid
from 13 patients and individual colonies from each spe-
c i m e nw e r eu s e dt op r e p a r e dD N Af o rC G H .N od i f f e r -
ences in chromosome copy number were observed for
the isolates from 11 of the patients (RCT23, RCT31,
HC2, HC3, HC5, RCT17, RCT50, RCT52, RCT55 (day
1), RCT55 (day 4) and RCT60 (data not shown, addi-
tional file 9). However, three different colonies from the
patient HC2 had divergent patterns of hybridization on
the CGH array containing the H99 genome, suggesting
sequence heterogeneity. Subsequent testing revealed that
these isolates were D serotype or molecular type VNIV
(data not shown). It is known that the genomes of A
and D strains exhibit sequence divergence of 5-10%
[18,29,30]. A divergent hybridization pattern was also
noted for two colonies of patient HC3 (HC-3a and HC-
3b), but a third colony (HC-3c) showed a tighter hybri-
dization pattern; this result also suggests that a mixed
infection of both serotype A and D strains was present
in HC3 (Additional file 9). This observation is reminis-
cent of the finding by Desnos-Ollivier et al. [28] that
mixed infections are relative l yc o m m o n( s e eD i s c u s s i o n
below). The colonies obtained from patient HC4 also
indicated a mixed infection because one colony showed
copy number elevation for part of chr 9 (indicating a
segmental duplication, Figure 8), and another colony
showed no copy number variation. Interestingly, a copy
number change at chr 6 was present in all three of the
isolates tested from patient HC6 (Figure 8). In these iso-
lates, it appeared that the chromosome was duplicated
but that one copy had a deleted region near the center
of the chromosome. It is possible that duplication of the
deleted region is not tolerated. FACS analysis indicated
that the HC-6 isolates were diploid (Additional file 10).
Overall, these results indicated that variation in chromo-
somal copy number was present in isolates from
patients with HIV/AIDS, and provided additional evi-
dence for mixed infections.
Discussion
Emerging evidence supports the view that the genome
of C. neoformans exhibits plasticity beyond the haploid
euploidy commonly observed in most clinical and envir-
onmental isolates [18,25-28,33]. As demonstrated here,
genomic variation such as aneuploidy appears to have a
major impact on the virulence of C. neoformans in a
mammalian host. However, detailed investigations are
needed to link specific changes to pathogenesis and the
clinical outcome of cryptococcosis. In our study, we
made the key observation that the black (monosomic)
and white (disomic) variants of CBS7779 differed in
their virulence in mice. This difference may be attribu-
ted to melanin formation because mutants defective in
m e l a n i na r ek n o w nt oh a v er e d u c e dv i r u l e n c ea n d
impaired dissemination to the brain [34-38]. However,
the numbers of yeast cells in lung and brain tissue were
similar for the black and white strains. These observa-
tions argue against melanin a st h es o l er e a s o nf o rt h e
difference in virulence. Rather, it appears that melanin
formation, although particularly sensitive to variation in
chromosome copy number in CBS7779, may be just one
of a number of traits affected by chromosomal changes.
That is, aneuploidy in general may impair virulence
through a number of mechanisms. For example, in
other fungi, such as S. cerevisiae, aneuploidy results in a
decreased growth rate and an imbalance in gene expres-
sion [39,40]. For C. neoformans,w ef o u n dt h a tw h i t e
strains grew more slowly in culture but their prolifera-
tion in the host was not impaired. Thus our in vitro
growth conditions did not reflect proliferation in vivo.
Our histopathological observations also suggested other
contributors to the observed difference in virulence. For
example, it appeared that infections with black strains
resulted in more airway remodeling and this damage
may account for the greater virulence. It is also possible
that the enhanced expression of genes on chr 13 that
we observed in the white strain created an imbalance in
gene expression that directly or indirectly influenced the
elaboration of known or unknown virulence factors. For
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pathology in the lung, and our observation that white,
disomic strains have increased sensitivity to brefeldin A
suggests an underlying perturbation of the secretory
pathway.
The discovery of disomy in strain CBS7779 raises the
question of whether this strain is particularly prone to
genome instability, perhaps due to background defects
in chromosome replication and segregation. The strain
was initially selected for CGH analysis because Boekhout
and van Belkum [41] reported that it had an unusually
small genome (15 Mb versus 18-27 Mb for other
strains). However, CGH did not reveal differences in
content relative to the reference genome of strain H99
[18]. In the current study, the ease in detecting addi-
tional chromosome changes in our analysis of second-
generation variants supports the possibility of general
genome instability in CBS7779. Conversely, chromo-
s o m ea n dp l o i d yc h a n g e sm a yb em o r ec o m m o nt h a n
previously appreciated in species of Cryptococcus,a s
indicated by reports of ext e n s i v eg e n o m ev a r i a t i o n
including karyotype variability and changes in clinical
and environmental strains of C. neoformans and C. gattii
in culture and in mammalian hosts [17,41-46]. The
study of Fries et al. [17] is particularly informative
because they found differences in karyotypes (rearrange-
ments and different numbers of chromosomes) in
sequential isolates of C. neoformans from AIDS patients.
In addition, they passaged strains through mice and
documented similar changes in karyotypes in cells
recovered for three of the six isolates. The karyotype
variations likely reflect translocations and segmental
changes, and it is possible that stress conditions in
mammalian hosts (e.g., oxidative, nitrosative and tem-
perature stresses) promote chromosome variation. In
our mouse passage experiments, the percentage of black
colonies recovered from tissue was higher than in the
starting inoculum, suggesting that they arose during
infection. Although we are cautious about drawing con-
clusions about the frequency of copy number variation
Figure 8
Figure 8 Chromosome copy number variation or segmental duplications are present in environmental and clinical strains. CGH analysis
revealed that strains A5-35-17 and JP1086 show copy number variation at chr 1 (whole chromosome) and 7 (segmental duplication),
respectively, among 19 clinical and environmental isolates. The analysis of isolates from the AIDS patients revealed two, HC-4 and HC-6, with
segmental duplications at chr 9 and chr 6, respectively. The “fuzzy” signal intensity for each chromosome in the HC-4 hybridization indicates that
the genome of this strain is divergent from the genome of the reference strain H99. This pattern is seen with strains that differ in molecular
subtype (VNII or VNB) from the VNI type of H99 [18]. The HC-6 strain was found to be diploid by FACS (Additional file 10) and this suggests that
the strain may contain one intact copy of chr 6 and one copy with a central deletion.
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subsequent qPCR and CGH analyses revealed multiple
chromosome changes in variants after passage in mice.
More detailed studies with tagged chromosomes and
fluctuation analysis will be needed to more closely
e x a m i n et h ef r e q u e n c yo fc o p yn u m b e rc h a n g ei na n i -
mals and in response to stress.
More recently, Sionov et al. [27] analyzed fluconazole
heteroresistance in the commonly studied C. neoformans
strain H99 and found copy number changes for several
chromosomes. In this case, selection for high-level resis-
tance was correlated with disomy for chrs 1 and 4, a
reduced growth rate and lower virulence. They also
found a difference in virulence between a fluconazole
resistant derivative H99 R64 and the parental H99
strain. Specifically, ~20% of the mice infected with the
disomic strain died by the end of the experiment com-
pared with ~50% inoculated with the wild-type strain.
The appearance of disomic chromosomes in flucona-
zole-resistant isolates also occurs in the related species
C. gattii [47,48]. In our study, we demonstrated that dis-
omy could be detected in strain H99 by tagging chr 13
with a neomycin resistance marker and selecting on
high levels of neomycin. However, some isolates showed
the expected amplification of chr 13 and others had
changes in different chromosomes. Together, these stu-
dies suggest that copy number variation is a common
property of C. neoformans.
Genomic variation in C. neoformans extends beyond
aneuploidy to include the occurrence of diploid strains
arising from a-a and same-sex mating, endoreplication
or clonal mating, as well as the formation of polyploid
cells in infected animals [19,20,25,49]. For example, Len-
geler et al. [19] examined 10 hybrid strains thought to
arise from the fusion of serotype A and D mating part-
ners, and they found that six were diploid and four were
aneuploid with DNA content between 1N and 2N. We
subsequently examined three of these AD hybrids by
CGH and found that some chromosomes were preferen-
tially retained from one parental genome or the other
[18]. For example, all three strains retained chr 1 from
the serotype A parent and lost the serotype D homolo-
gue. A survey of an additional 16 AD hybrid strains
revealed that chr 1 from the A serotype genomes was
preferentially retained in 11 of the isolates [18].
Recently, Lin et al. [20] surveyed 489 clinical and envir-
onmental strains of A serotype and found that 7.8%
were diploid based on fluorescence flow cytometry.
Thus diploid strains are relatively common, although in
c o n t r a s t ,o n l ys i xo ft h ei s o l a t e sa p p e a r e dt ob ea n e u -
ploid. Characterization of laboratory-constructed
diploids demonstrated that elevated ploidy has a minor
negative influence on virulence in mice, and it is clear
that diploids contribute to the disease spectrum because
of the occurrence of these strains and mixed infections
in AIDS patients [28,49]. Interestingly, Desnos-Ollivier
et al., [28] showed that mixed infections with strains of
different mating type, serotype, genotype and ploidy
occur at a high frequency (18.4%) in patients; many of
the isolates (8/23) in this study were diploid. Multilocus
sequence typing indicated that some of the isolates may
have arisen through diploidization (endoreplication). In
our analysis, one strain from an AIDS patient (HC-6)
appeared to be diploid with a copy number difference at
chr 6. An isolate from a second patient (HC-4) also con-
tained an elevated copy number for a segment of chr 9.
Additional complexity comes from the discovery of tet-
raploid or octoploid cells that arise as a proportion of
cryptococcal cells in the lungs of infected mice [25,26].
It is possible that disomy may result from the reduction
in chromosome number as cells transition from the
diploid or polyploid states to the haploid complement of
chromosomes. Overall, the emerging view is that aneu-
ploidy and changes in ploidy are common features of C.
neoformans.
T h eo c c u r r e n c eo fa n e u p l o i d yi nC. neoformans is
reminiscent of the situation in other fungal pathogens,
and especially in the pathogenic yeast Candida albi-
cans [11]. The diploid genome of this fungus exhibits a
high level of plasticity, as strains with chromosomal
rearrangements, loss of heterozygosity and aneuploidy
are frequently observed. In addition, mating between
diploid strains yields tetraploid strains that do not
undergo meiosis but instead display random chromo-
some loss. As in C. neoformans, clinical isolates of C.
albicans show considerable genomic diversity with the
detection of translocations, chromosomal truncations
and the formation of extra chromosomes. Elegant stu-
dies have shown that whole-chromosome or segmental
aneuploidy can readily be detected by CGH and that
this variation is associated with a growth advantage on
L-sorbose or D-arabinose and with resistance to fluco-
nazole [7,11-15,50-52]. Considerable genomic variation
also occurs during growth in mammalian hosts and it
has been found that aneuploidy influences virulence
[6,8,9,11,53,54]. Changes during DNA transformation
also are observed in C. albicans and our observations
on the appearance of disomic strains during neomycin
selection indicates that similar variation may occur in
C. neoformans [55,56]. Chromosome variation is also a
feature of the haploid yeast pathogen Candida glab-
rata. Specifically, Poláková et al. [57] examined the
chromosome complements of4 0c l i n i c a li s o l a t e sa n d
found considerable variation including frequent exam-
ples of translocations, segmental duplications and the
appearance of novel chromosomes. The sequences in
regions of variation may influence interactions with
the host and disease outcomes because they encode
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transporters. In fact, an isolate carrying a novel mini-
chromosome showed increased tolerance to
fluconazole.
Conclusions
The genome variability documented here and in earlier
work [17,18,27] could influence the virulence and persis-
tence of C. neoformans, and therefore impact disease
outcome. Cryptococcal meningoencephalitis is difficult
to treat, particularly in AIDS patients because of the
persistence of the fungus (especially in the central ner-
vous system). Long-term antifungal drug therapy is
sometimes necessary to prevent the recurrence of cryp-
tococcosis in these patients [58]. Changes in ploidy and
reversible chromosome copy number during infection
likely mediate changes in gene expression and pheno-
type that could impact latency, chronic infection, anti-
fungal drug susceptibility and the response to host
defenses. Certainly aneuploidy is beneficial in the
response to stress in other fungi, and both aneuploidy
and polyploidy may provide mechanisms for cells to
generate adaptive variability and deal with environmen-
tal challenges [13,15,59-63]. In general, it is important
to understand the genetic flexibility of the pathogen as
an aspect of efforts to control infection, and a number
of important questions remain. These include whether
propagation in culture versus the host environment pre-
ferentially results in chromosome variation and whether
selective pressure in the host (oxidative, nitrosative and
temperature stress, and nutrient limitation) influences
chromosome instability. It will also be important to
determine whether specific chromosomal changes and
underlying alterations in the expression of virulence fac-
tors contributes to adaptation in different host tissues,
to latency, and to resistance to host defense mechan-
isms. The answers to these questions will reveal the
range of phenotypic changes determined by copy num-
ber change at each chromosome, and further establish
relevance to disease.
Methods
Strains and growth conditions
The strains for this study are listed in Additional file 7
and were maintained on yeast extract, peptone, dextrose
medium (YPD; Difco). To screen for variants of strain
CBS7779, single colonies were grown in liquid YPD
overnight at 30°C, and plated on L-DOPA medium ((0.5
mM 3,4-hydroxy-L-phenylalanine [L-DOPA], 1 mM
MgSO4 · 7H2O, 22 mM · KH2PO4,3μM thiamine-HCl,
0.1% glucose, 0.1% L-asparagine, pH 5.6) at ~500 cells
per plate. The plates were incubated at 30°C for 3 days
and melanin production (darker or lighter colony pig-
mentation) was evaluated visually. Strains from the
cerebral spinal fluid of AIDS patients were obtained by
plating directly on YPD plates. To minimize the poten-
tial influence of prolonged culture on chromosome
number, single colonies were picked and individually
cultured in 50 ml YPD overnight prior to genomic DNA
isolation. Growth in liquid yeast nitrogen base medium
was monitored in a TECAN plate reader over 72 hours.
To insert a selectable marker on chr 13 of strain H99,
a construct containing the neomycin resistance cassette
was prepared by overlapping PCR and introduced by
biolistic transformation [64]. The construct replaced a
fragment of 31 base pairs in an intergenic region (chr
13: 316840-316870). The primer sequences for the con-
struct are given in Additional file 11. Transformants
were screened by colony PCR and four positive strains
with the correct insertion of the neomycin resistant cas-
sette (#s 32, 33, 34 and 35) were selected. A single col-
ony of each tagged strain was grown in YPD overnight
at 30°C and then plated on L-DOPA medium containing
neomycin (2 mg/ml). After three days at 30°C, black and
white colonies were collected, genomic DNA was iso-
lated and qPCR and/or CGH analysis was employed to
examine the copy number of chr 13 as described [18].
Comparative Genome Hybridization
The genomic DNA for hybridization experiments was
isolated as previously described [18]. The genomic
sequence of H99 was retrieved from the Cryptococcus
neoformans var. grubii H99 Sequencing Project, Broad
Institute of Harvard and MIT (http://www.broadinsti-
tute.org/). The assembled sequences were used by Nim-
bleGen Systems, Inc. (Madison, WI) to design and
manufacture the oligonucleotide genomic arrays.
Because the focus of this study was on chromosome
copy number changes, rather than the duplication/dele-
tion of single genes or genome fragments, the design for
the arrays was modified for our earlier design [18], with
oligonucleotide probes that cover all 14 chromosomes
of H99 tiled at an average interval spacing of 133 bp on
one strand. The average length of each probe was 50 bp
(range 45 to 85 bp) and the average Tm of the probes
on each array was 76°C. The number of oligonucleotide
probes for this new design for H99 was 134, 953. The
probes for each array were designed to uniquely match
a single sequence in the genome and highly repetitive
centromeric regions and the rDNA repeat cluster were
not included. The hybridization procedures, data acqui-
sition and analysis were as previously described [18].
Phenotypic assays
Melanin production was examined on solid L-DOPA
medium. Capsule measurements, and stress- and drug-
response assays were performed as previously described
[32,65]. Briefly, exponentially growing cultures of test
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to 2 × 10
4 cells/μl. The cell suspensions were serially
diluted 10-fold, and 5 μl of each dilution was spotted on
YPD and/or YNB plates supplemented with or without
20 μg/ml or 40 μg/ml brefeldin A, 0.5 mg/ml monensin,
or 5 μg/ml fluconazole. Plates were incubated for two to
five days at 30°C or 37°C and photographed. To esti-
mate the frequency of spontaneous emergence of color
variants in vitro,~ 3×1 0
4 cells of each strain were pla-
ted onto L-DOPA medium. After 72 hours of incubation
at 30°C, dark colonies originating from a white parent
(e.g., CBS7779-W1, -W2, or -W3), or white colonies
from a black parent, were identified, and frequencies
were estimated by dividing the number of variant colo-
nies by the total CFU. A similar method was used to
estimate the frequencies of changes in melanization in
vivo; the percentages of colonies of the total fungal load
in each organ with color variant to parental phenotype
was assessed.
Virulence assays and histopathology
The virulence of each strain was examined using
female BALB/c mice (4 to 6 weeks old) from Charles
River Laboratories (Ontario, Canada). Fungal cells were
grown in 5 ml of YPD at 30°C overnight, washed twice
with PBS (Invitrogen, Canada), and resuspended in
P B S .T h eB A L B / cm i c e ,i ng r o u p so f1 0 ,w e r ea n e s t h e -
tized intraperitoneally with ketamine (80 mg/kg of
body weight) and xylazine (5.5 mg/kg) in PBS and sus-
pended on a silk thread by the superior incisors. A
suspension of 5 × 10
4 cells in 50 μl was slowly dripped
into the nares of the anesthetized mice, and the mice
were suspended for 10 minutes on the thread. The
number of cells in each inoculum was confirmed by
CFU determination after plating serial dilutions. The
health status of the mice was monitored daily post-
inoculation. Mice reaching the humane endpoint were
euthanized by CO2 anoxia. All ten mice from each
infection group were used at the endpoint to assess
fungal loads in organs. Following euthanasia, the brain
and the lungs were aseptically removed and immersed
in 1 ml sterile PBS containing a metal bead. Organs
were homogenized using an automated tissue homoge-
n i z e r( R e t s c h ,P A ,U S A ) .T h es a m p l e sw e r es e r i a l l y
(1:10) diluted and 100 μlo f1 0
-4 and 10
-5 dilutions
were plated and spread with 4 mm glass beads on L-
DOPA medium containing 100 μg/ml chloramphenicol.
After 3 days of incubation at 30°C, the L-DOPA plates
were photographed using a Nikon Coolpix 990 camera.
The images were opened with AlphaImager 3400, and
the CFUs were digitally assessed by AlphaEase FC soft-
ware (Alpha Innotech, San Leandro, CA). The number
of color variants was tallied manually.
Female BALB/c mice (8 weeks old) from Charles River
Laboratories (Ontario, Canada) were used in histopathol-
ogy experiments to examine whether CBS7779-B4 and
CBS7779-W2 cells elicited differential immune responses
and/or exhibited different dissemination efficiency in
vivo. Groups of nine mice were inoculated as described
above, and on days 7, 14, and 21 post-infection, three
mice from each group were euthanized by CO2 asphyxia-
tion, and lungs and brains were immediately fixed in 10%
neutral buffered formalin. Tissue embedding and section-
ing (5 μm) were prepared by Wax-IT Histology (Vancou-
ver, Canada) and stained with hematoxylin and eosin
(H&E) or Mayer’s mucicarmine (MM) to visualize the
cryptococcal capsule. Lung slides were examined by light
microscopy (AxioSkop 2 MOT, Carl Zeiss Ltd, Canada)
in a blinded fashion and scored for degree of fungal infil-
tration, tissue damage and inflammation. Brain sections
were examined by light microscopy for the presence and
distribution of cryptococcal cells.
All experiments with animals were conducted accord-
ing to guidelines set by the Canadian Council on Ani-
mal Care. The protocol (A08-0586) for the virulence
assays with mice was approved by the University of Brit-
ish Columbia’s Committee on Animal Care (Animal
Welfare Assurance Number A5090-01). C. neoformans
isolates from patients were obtained as part of the Data-
base and Specimen Repository for Infectious Disease-
Related Studies (reference number CR3_Pro00005314),
as approved the Duke University Internal Review Board.
Statistical analyses
Statistical analysis of survival differences was performed
by Kaplan-Meier survival curves and log rank tests. An
unpaired, two-tailed t-test was used to determine the dif-
ferences in mean CFU per organ (i.e., brain and lung)
between mice inoculated with different strains. A P-value
of 0.05 or less was considered significant. All statistical
analyses were carried out using GraphPad Prism version
4 for Windows (GraphPad Software, San Diego, CA).
Quantitative real-time PCR
Quantitative real time PCR was used to confirm the
copy number of chromosomes 4 and 13 in selected
colonies as previously described [18]. Each reaction mix-
ture contained 100 ng of template DNA, 0.25 μM of for-
ward and reverse primers, and Power SYBR Green PCR
Master Mix (Applied Biosystems). An ABI 7500 instru-
ment (Applied Biosystems) was used for signal detection
and data collection. Primer sequences for genes
CNA04650 (actin), SMG1 (chr 4), 00_070 (chr 4) and
CNN00820 (chr 13) were used for CCNV determination,
as listed in Additional file 12 and as previously
described [18].
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To examine the genomic profile of the original parental
strains (CBS7779, CBS7779B4-6, CBS7779W1-3) and
selected strains harvested post-infection, flow cytometry
was performed as described [49], with slight modifica-
tions. Briefly, overnight cultures were centrifuged at
10,000 rpm for 1 minute, washed once with 1 mL of
distilled water, and 1 × 10
7 cells were harvested and
fixed in 70% ethanol overnight at 4°C. Subsequently, the
ethanol was removed and the cells were washed with
NS buffer (10 mM Tris-HCl [pH 7.6], 250 mM sucrose,
1 mM EDTA [pH 8.0], 1 mM MgCl2, 0.1 mM CaCl2,
0.1 mM ZnCl2), and stained with 10 μg/mL propidium
iodide (Sigma) in 0.5 mL NS buffer containing 1 mg/mL
R N a s eA( R o c h e )a t4 ° Co v e r night. The stained cells
were then suspended in 50 mM Tris-HCl (pH 8.0)
(without sonification). Propidium iodide fluorescence
was analyzed using a BD FACSCalibur (BD Biosciences,
Canada) on the FL3 channel. Graphs and histograms
were generated using Flowjo v8.8.6 (Ashland, OR).
RNA labeling and microarray analysis
The strains CBS7779-W2 and CBS7779-B4 were used for
microarray analysis. Three independent biological repli-
cates for each strain were grown in 25 ml of YPD over-
night at 30°C. Cells were washed twice with water, re-
suspended in L-DOPA medium and then incubated at 30°
C for 6 h prior to RNA extraction. RNA was purified with
the RNeasy kit (Qiagen) and treated with DNase (Qiagen)
following the manufacturer’s recommendations. The qual-
ity of the RNA was analyzed with an Agilent 2100 Bioana-
lyzer. cDNA synthesis, labeling with Cy3 or Cy5, and array
hybridization to 70-mer microarrays (version 2.0, http://
www.mogene.com were performed by Mogene (MO,
USA). Dye-swap experiments were performed for all
hybridizations. Modification of the gene list of microarray
probes was described previously [66]. Single 60-mer oligo-
nucleotide probes were designed for each of the ORFs and
were duplicated on the microarray to provide an estimate
of intra array variance. Of the 7,302 ORFs designated by
the Broad Institute, 100 ORFs were eliminated because the
sequences were of low complexity. The probes covered
6,932 of the final annotated genes. Agilent Technologies
fabricated the arrays.
After ANOVA normalization, genes showing log2-
transformed fold changes (P <0 . 0 5 )w e r es e l e c t e df o r
further analyses. To classify genes by their functions, a
web-based program, CateGOrizer (http://www.animalge-
nome.org/bioinfo/tools/catego/), was used [67]. The
heatmap was generated using the “heatmap.2” routine in
the package gplots after the gene expression data were
normalized using R-package, by limma with options of
‘minimum’ background correction, ‘Lowess’ within-array
normalization, and ‘quantile’ between-array normaliza-
tion as recommended [68].
Additional material
Additional file 1: Genes up-regulated in the black strain B4 (Table
S1). A microarray comparison of the transcriptomes of the black B4
isolate and the white W2 isolate identified genes with greater than two-
fold elevated transcript levels in the B4 isolate.
Additional file 2: Genes up-regulated in the white strain W2 (Table
S2). A microarray comparison of the transcriptomes of the black B4
isolate and the white W2 isolate identified genes with greater than two-
fold elevated transcript levels in the W2 isolate.
Additional file 3: Comparison of gene expression for a second-
generation black strain (Figure S1). Gene expression was compared
for the CBS7779-B4 strain and the “second generation” black strain
CBS7779-W2BA by microarray analysis. Strain CBS7779-W2BA was
obtained from the white strain CBS7779-W2 (Figure 1). Two arrays were
employed and two biological repeats were performed to examine
transcript levels. Columns 1 and 2 each represent a microarray
experiment and each row represents the expression of a gene on the
array arranged by its chromosomal position. The relative expression
levels are represented by color as shown in the bar.
Additional file 4: CGH analysis of additional strains with
chromosome copy number variation (Figure S2). Passage of the
white variant CBS7779-W2 (disomic for chr 13) in culture and analysis of
black or white isolates by CGH revealed changes at additional
chromosomes. The black variant W2-BB showed copy number increase
for a segment of chr 12, and the white isolate W2-WB gained a
segmental changes for chr 12 and chr 14. The black variant strain
CBS7779-B1 was confirmed to be monosomic by CGH and additional
variants were identified in culture (Figure 6). In addition, white variants of
strain B1 were subsequently screened for black variants (B1-WC-B1,
disomic for chr 13; B1-WC-B4, monosomic for all chromosomes).
Additional file 5: CGH analysis of additional strains obtained from
mice (Figure S3). Passage of the CBS7779 variants W2, W3 and B6 in
mice lead to variation at chr 4 and chr 13. As described in the text and
presented in Figure 6, white and black strains collected from the lungs
and brains of mice infected with CBS7779 variants were compared to the
reference genome of strain H99 by CGH.
Additional file 6: Phenotypic characterization of variants of the
laboratory strain H99 (Figure S4). (A) The screen for variants with
reduced melanin production is shown for tagged strains on L-DOPA
medium containing neomycin. This procedure yielded the strains
analyzed in Figure 7. (B) The capsule size and cell morphology of the
variants were examined with india ink staining. This size bar is 10 μm. (C)
Summary of the phenotypes of each variant.
Additional file 7: Strain list (Table S3). The strains employed in the
study are listed in Table S3.
Additional file 8: CGH analysis of 18 clinical and environmental
strains (Figure S5). The strains were analyzed along with strains A5-35-
17 and JP1086 (Figure 8) using the array for the reference strain H99.
Additional file 9: CGH analysis of isolates from HIV/AIDS patients
(Figure S6). Three isolated colonies were tested for patients HC-2, HC-3
and HC-5, and a representative colony is shown for the three colonies
from patient HC-6. The analysis of another HC-6 colony is shown in
Figure 8 (all three colonies had the same chromosome complement).
Additional file 10: Analysis of three HC-6 isolates by fluorescence-
activated flow cytometry (Figure S7). The ploidy of the three isolates
from patient HC-6 were examined and the haploid strain H99 and the
diploid strain KW5 were included as controls.
Additional file 11: Primer list for strain construction (Table S4). The
primers employed to insert a selectable marker on chr 13 of strain H99
are listed in Table S4.
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Page 16 of 19Additional file 12: Primer list for qPCR (Table S5). The primers
employed for quantitative real time PCR to confirm the copy number of
chromosomes 4 and 13 are listed in Table S5.
Abbreviations
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